Replies to post #105880 on Anavex Life Sciences Corp (AVXL)

[bas2020]

I'm holding MacFarlane to his word! He said in January that the Alz P2/3 will start before midyear. He should know, he's the one running the trial. He has roughly 5 weeks left! Come on, Steve; you said! :-)

[McMagyar]

No telling what the delay is..
So many irons in the fire even the good Dr has to be feeling the heat..

And we are only talking about A2-73!

We have drugs for Cancer and Pain Relief that have incredible pre clinical data as well

Not even mentioning A3-71..

And a Platform creating more..

Anavex Plus Patent is big IMO because it shows Anavex is capable of getting "Rights" by combining A2-73.. to another treatment..

Than you see APP for Epilepsy Patent is based on Adjunctive Therapy.. and you realize the good Dr is probably filing Patents with PLUS therapies for every indication under the Son..

Why would you broadcast that to Big Pharma? Why would you give anyone anymore info than what you have to?

We are longs because we believe in the science..
we already KNOW a2-73 works..

Because it has worked already..

Ergo..therefor.. it works..

And since it works by restoring Homeostasis. ..


We know ergo, therefor it works for
Treatment for EVERY InDication.

It is simple logic. We are NoT treating Any Disease.. get it?

We are not curing any disease? Understand?

Our Drug creates Cellular Homeostasis and
the Body Cures/treats Itself.


We have seen and know that Homeostasis properly encourages and powered by Sigma 1 Ligand
May even stop and reverse Alzheimers..


What else do you need?

Accumulate.

AnavexNOW

[kld2]

September? They were talking about the 1H; Macfarlane mentioned it in an interview. Remember the Australian radio spots? If that's the case, you can say goodbye to the 5s. Actually, this is quite irritating. But, I'm sure, Missling is in no hurry: just rakes in another 10-11m, what the hell! Getting irritating, to be honest; no real news. I think AF's right: mice ado about nothing.

[Talon38]

Attila,

Watch for FDA "Breakthrough Therapy" and additional "Orphan Dug" designation and an NIA Alzheimer's grant. A little nudge from Scott Gottlieb.